BioCentury
ARTICLE | Company News

Ludwig Institute, University of Oxford, iOx Therapeutics deal

September 7, 2015 7:00 AM UTC

The university’s Isis Innovation Ltd. tech transfer arm and Ludwig Cancer Research will spin out and form iOx Therapeutics. The newco will develop synthetic lipid cancer immunotherapeutics that activa...